Alex Soriano
Jefe del Servicio de Enfermedades Infecciosas Especialista en enfermedades infecciosasGrupo de investigación
- Infección nosocomial Group leader (R4)
Publicaciones destacadas
-
Safety and efficacy of prolonged use of dalbavancin in bone and joint infections
Autores:Referencia: Antimicrobial Agents And Chemotherapy 2019. -
Clinical outcome and risk factors for failure in late acute prosthetic joint infections treated with debridement and implant retention.
Autores:Referencia: Journal Of Infection 2019. -
Short-Term Peripheral Venous Catheter-Related Bloodstream Infections: Evidence for Increasing Prevalence of Gram-Negative Microorganisms from a 25-Year Prospective Observational Study.
Autores:Referencia: Antimicrobial Agents And Chemotherapy 2018. -
Preliminary Results After Changing From Two-Stage to One-Stage Revision Arthroplasty Protocol Using Cementless Arthroplasty for Chronic Infected Hip Replacements.
Autores:Referencia: Journal Of Arthroplasty 2018. -
Clinical experience with ceftazidime/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas aeruginosa
Autores:Referencia: International Journal Of Antimicrobial Agents 2017. -
Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention-authors' response
Autores:Referencia: Journal Of Antimicrobial Chemotherapy 2016. -
KLIC-score for predicting early failure in prosthetic joint infections treated with debridement, implant retention and antibiotics
Autores:Referencia: Clinical Microbiology And Infection 2015. -
Prosthetic joint infection due to Enterococcus sp treated with debridement, antibiotics and retention of the implant (DAIR)
Autores:Referencia: Clinical Microbiology And Infection 2015.
Proyectos destacados
-
Stability and viability of lyophylized microbiota and its usefulness for the treatment of Clostridium difficile infection
Investigador/a principal: Alex Soriano ViladomiuFinanciador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Instituto de Salud Carlos III (ISCIII)Código: PI16/01023Duración: 01/01/2017 - 31/12/2019 -
Diseño y evaluación de pruebas para el diagnóstico de biopelículas bacterianas sobre biomateriales. Aplicación en infecciones sobre prótesis articulares.
Investigador/a principal: Alex Soriano ViladomiuFinanciador: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento); Instituto de Salud Carlos III ; Instituto de Salud Carlos III (ISCIII)Duración: 01/01/2014 - 01/01/2016 -
Design and evaluation of diagnostic tests for the diagnosis of bacterial biofilms on biomaterials. Aplication in prosthetic joint infections
Investigador/a principal: Alex Soriano ViladomiuFinanciador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Instituto de Salud Carlos IIICódigo: PI13/01754Duración: 01/01/2014 - 01/01/2016 -
Pharmacokinetic evaluation and pharmacodynamics of the initial treatment with meropenem, ceftazidime, piperaciclina-tazobactam and colistin in critically ill patients with sepsis
Investigador/a principal: Juan Antonio Martínez, Juan MartínezFinanciador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Instituto de Salud Carlos IIIDuración: 01/01/2012 - 31/12/2014 -
A Phase III multi-center, randomized, open-label, comparative study to assess the efficacy of a treatment algorithm to reduce the use of vancomycin in patients with intravenous catheter-associated bloodstream infections (BSI) due to Staphylococci
Financiador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); National Institute of Health (NIH)Código: NIHAI2008025Duración: 23/05/2011 - 08/07/2015